Tenderwize
Back to tender search

Open-house rebate agreement for Glatirameracetat injection solution in a prefilled syringe

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 472 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Injektionslösung in einer Fertigspritze, ATC L03AX13

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

The buyer explicitly states this is an open-house model and not a normal open procedure; procurement-law remedies and c...

Contract documents must be submitted via the communication area, not the offer area; paper originals must be in duplica...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive open-house rebate agreements for Glatirameracetat in the form of injection solution in a prefilled syringe, ATC L03AX13.
  • Supply of pharmaceutical products under identical, pre-set contract terms.
Show full summary

This is an open-house pharmaceutical rebate agreement for Glatirameracetat injection solution in a prefilled syringe (ATC L03AX13) offered by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 01.02.2026 to 31.01.2028, with accession possible until 03.12.2027. Submission is either by handwritten originals in duplicate or electronically with a qualified electronic signature via DTVP. No contract value is provided.

Risks

The buyer explicitly states this is an open-house model and not a normal open procedure; procurement-law remedies and c...

Contract documents must be submitted via the communication area, not the offer area; paper originals must be in duplica...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract must be completed and signed, together with the annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Glatirameracetat injection solution in a prefilled syringe

Single lot covering non-exclusive open-house rebate agreements for the medicinal product Glatirameracetat in injection solution in a prefilled syringe, ATC L03AX13. The lot is for supplies and appears to be a framework/open-house arrangement with no negotiated individual terms. The lot information comes from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Dec 03, 2027

Procurement Details

Publication date
14 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
830560-2025

Documents (2)

Similar tenders